文献速递衰弱、肌少症与跌倒老年综合评估

血浆神经丝轻链与颗粒体蛋白前体同老年人衰弱的关联

Associations of plasma neurofilament light chain and progranulin with frailty in older adults.
PubMed 文献 · J Am Geriatr Soc · 2021-12-15

该研究纳入MAPT试验中507名社区老年人(平均年龄76.7岁),在调整分析中未发现血浆NfL和PGRN水平与衰弱存在显著关联,高龄NfL仅在未调整模型中与衰弱前期或衰弱相关,两者均不能预测4年内新发衰弱。

要点

  • 调整协变量后,血浆NfL与PGRN水平均与衰弱无显著关联。
  • 基线高NfL(>93.11 pg/ml)仅在未调整模型中与衰弱前期或衰弱相关。
  • NfL和PGRN均不能预测4年内新发衰弱。

核心结论

  • 调整分析未发现社区老年人血浆NfL和PGRN水平与衰弱存在关联。

研究设计与样本

  • 基于MAPT试验的507名社区老年人,平均年龄76.7岁,血浆NfL和PGRN测量时间点(入组后12或24个月)定义为基线。
  • 采用Fried衰弱标准在12、24、36、48和60个月评估衰弱表型。
  • 横断面关联用logistic回归分析,基线robust或pre-frail者(n=403)的新发衰弱用Cox比例风险模型评估。

主要发现

  • 基线高血浆NfL(>93.11 pg/ml,上四分位数)者衰弱前期或衰弱的似然比更高(OR=1.68;95%CI=1.10-2.57),但控制协变量后该关联不再显著。
  • NfL和PGRN水平均未显示与4年内新发衰弱的前瞻性关联。

关键数值与推荐

  • 高NfL定义为>93.11 pg/ml(上四分位数)。
  • 横断面关联OR=1.68;95%CI=1.10-2.57(未调整协变量)。

临床怎么用

  • 目前证据不支持将血浆NfL或PGRN作为社区老年人衰弱的常规生物标志物。
  • 对高NfL老年人可关注衰弱风险,但需结合其他临床评估,不宜单独据此判断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In previous studies, plasma neurofilament light chain (NfL) and progranulin (PGRN) levels are associated with cognitive and physical impairment in older individuals. However, evidence of their relationships with frailty is lacking. This study aims to explore the associations of plasma NfL and PGRN levels with frailty in community-dwelling older adults. METHODS: We included 507 older adults (mean [standard deviation] age, 76.7 [4.5] years) with plasma NfL and PGRN measurements from the Multidomain Alzheimer Preventive Trial (MAPT). The timepoint of biomarker measurements, either 12 or 24 months after study enrollment, was defined as the baseline for each participant. Frailty phenotype (robust, pre-frail, and frail) was assessed at 12, 24, 36, 48, and 60 months by Fried's frailty criteria. The cross-sectional associations between plasma neurodegenerative biomarkers and frailty severity were examined using logistic regressions. We further used Cox proportional hazard models to evaluate the associations between plasma biomarkers and incident frailty among robust or pre-frail participants at baseline (n = 403). RESULTS: At baseline, participants with high plasma NfL levels (>93.11 pg/ml [the upper quartile]) had a higher likelihood of pre-frailty or frailty compared to their normal NfL counterparts (odds ratio = 1.68; 95% confidence interval = 1.10-2.57); however, this association did not remain significant after controlling for covariates. Neither NfL nor PGRN levels showed prospective associations with incident frailty over 4 years. CONCLUSIONS: This study failed to find associations of circulating NfL and PGRN levels with frailty among community-dwelling older adults in adjusted analyses. Whether plasma neurodegenerative markers serve as potential biomarkers of frailty requires further investigation.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Lu WH, Giudici KV, Guyonnet S, et al. Associations of plasma neurofilament light chain and progranulin with frailty in older adults. J Am Geriatr Soc. 2021. PMID: 34908159. doi:10.1111/jgs.17604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。